PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis b |
| Symptom | |liver fibrosis |
| Sentences | 81 |
| PubMedID- 23431353 | Additionally, a multicenter, randomized, double-blinded, and parallel control experiment demonstrated that fzhy had good therapeutic effects on improving liver fibrosis due to chronic hepatitis b . |
| PubMedID- 23724041 | The natural history of liver fibrosis progression in patients with chronic hepatitis b (hbv) or c virus (hcv) infection is highly variable and depends on both host and viral factors 1. |
| PubMedID- 24521427 | Transient elastography should not be used to assess liver fibrosis during acute flares of viral hepatitis because readings are falsely elevated. |
| PubMedID- 20796157 | Simpler score of routine laboratory tests predicts liver fibrosis in patients with chronic hepatitis b. |
| PubMedID- 24751289 | Background & aims: accurate assessment of liver fibrosis in patients with chronic hepatitis b (chb) is necessary not only to predict the long-term clinical course but also to determine an appropriate antiviral therapy scheme. |
| PubMedID- 22536445 | Accurate assessment of the severity of liver fibrosis in patients with chronic hepatitis b (chb) is necessary not only for predicting the long-term clinical course, but also for determining whether and when to begin antiviral therapy. |
| PubMedID- 24814578 | Telbivudine therapy may shape cd4(+) t-cell response to prevent liver fibrosis in patients with chronic hepatitis b. |
| PubMedID- 25785082 | Noninvasive predictive models of liver fibrosis in patients with chronic hepatitis b. |
| PubMedID- 25897319 | This article reviews natural products and herbal medicines that have demonstrated activity against liver fibrosis through different mechanisms of action, including anti-hepatitis b and c virus activity, anti-inflammation, inhibition of cytokine production and nuclear receptor activation, and free radical scavenging. |
| PubMedID- 24581967 | Aim: to evaluate whether the relative apparent diffusion coefficient (radc) can help determine the stage of liver fibrosis in patients with chronic hepatitis b virus (hbv) by using the spleen and renal cortex as reference organs. |
| PubMedID- 26300933 | Objectives: the current randomized controlled clinical trials aimed to evaluate the efficacy of combinations of antiviral and non-antiviral hepatoprotective agents on indexes of liver function and liver fibrosis in patients with hepatitis b. |
| PubMedID- 22698510 | Comparative study concerning the value of acoustic radiation force impulse elastography (arfi) in comparison with transient elastography (te) for the assessment of liver fibrosis in patients with chronic hepatitis b and c. |
| PubMedID- 22796373 | Comparison of lect-hepa and fibroscan for assessment of liver fibrosis in hepatitis b virus infected patients with different alt levels. |
| PubMedID- 20395100 | We investigated whether dw-mri predicts postoperative hepatic insufficiency and liver fibrosis in patients with hepatitis b virus (hbv)-related hepatocellular carcinoma (hcc). |
| PubMedID- 21567462 | In this study, we aimed to research the correlation of mean platelet volume (mpv) and stage of liver fibrosis in patients with chronic hepatitis b (chb). |
| PubMedID- 20441599 | Our previous studies showed that sal b had obvious therapeutic effects against liver fibrosis in patients with chronic hepatitis b and animal models induced by dimethylnitrosamine , and its mechanism was closely associated with the inhibition of hepatic stellate cell activation through the regulation of tgf-β/smads signaling . |
| PubMedID- 22675458 | Clinical trials are currently underway using a fully human igg1κ monoclonal antibody that recognizes domain 2 of human and rodent ctgf (this monoclonal is called fg-3019 and was developed by fibrogen, inc., south san francisco, ca) as a novel therapy to treat patients with pancreatic cancer, idiopathic pulmonary fibrosis, and liver fibrosis due to chronic hepatitis b infection . |
| PubMedID- 22338213 | Conclusion: liver fibrosis staging in patients with chronic hepatitis b is a risk factor for p53 positive expression in liver. |
| PubMedID- 24252854 | Withdrawn: noninvasive predictive models of liver fibrosis in patients with chronic hepatitis b. |
| PubMedID- 24282481 | In this study, we investigated associations between serum cp levels and inflammation grade and liver fibrosis stages in patients with chronic hepatitis b-virus related liver disease. |
| PubMedID- 24735138 | Commentary: coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis b - authors' reply. |
| PubMedID- 21216123 | Conclusions: real-time elastography with a new quantitative technology for diffuse histological lesion is a new and promising sonography-based noninvasive method for the assessment of liver fibrosis in patients with chronic hepatitis b. |
| PubMedID- 22261202 | Objective: to investigate the performance of different b values and regions of interest (roi) for diagnosing liver fibrosis in patients with chronic viral hepatitis by using diffusion-weighted (dw) magnetic resonance imaging (mri). |
| PubMedID- 23325286 | Can mean platelet volume determine the severity of liver fibrosis or inflammation in patients with chronic hepatitis b. |
| PubMedID- 21140473 | Accelerated liver fibrosis in hepatitis b virus transgenic mice: involvement of natural killer t cells. |
| PubMedID- 21286337 | Background: liver stiffness measurement (lsm) can assess liver fibrosis in patients with chronic hepatitis b (chb). |
| PubMedID- 23445460 | We designed a non-invasive method, called magnetic resonance laparoscopy (mrl), based on gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging, to assess liver fibrosis in patients with chronic hepatitis b and c virus. |
| PubMedID- 21235598 | Transient elastography and biomarkers for liver fibrosis assessment and follow-up of inactive hepatitis b carriers. |
| PubMedID- 25761184 | We aimed to study whether red blood cell distribution width (rdw) could be one of the variables determining the extent of liver fibrosis and inflammation in patients with biopsy-proven hepatitis b. |
| PubMedID- 22848675 | Accurate assessment of the severity of liver fibrosis in patients with chronic hepatitis b (chb) is necessary for not only prediction of the long-term clinical course, but also determination of whether and when to begin antiviral therapy. |
| PubMedID- 22613424 | Clinical utility of serum matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 concentrations in the assessment of liver fibrosis due to chronic hepatitis b. |
Page: 1 2